TESTSTSARDSAR DEA Reportedly Set to Reschedule Cannabis to Schedule III by Sara Brittany Somerset In a paradigm shift, the U.S....
GAINERS: Elixinol Wellness (OTC:ELLXF) shares closed up 110.00% at $0.01 Item 9 Labs (OTC:INLB) shares closed up 100.00% at $0.0002...
In a reversal for organized labor after years of positive momentum in the regulated marijuana industry, employees at a Cresco...
The global cannabis trifecta has hit! The United States has finally rescheduled cannabis, moving it to Schedule III; the Department...
In response to reports of the Drug Enforcement Administration’s (DEA) reclassification of cannabis from Schedule I to Schedule III under...
U.S. Drug Enforcement Administration (DEA) has proposed the rescheduling of cannabis from Schedule I to Schedule III under the Controlled...
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to...
DEA’s Move To Reclassify Cannabis Seen As ‘Significant,’ But Fails To Resolve State-Federal Conflict
For the first time ever, the Drug Enforcement Administration (DEA) has reportedly called for ‘botanical cannabis' to be reclassified under...
In a landmark decision that could reshape the landscape of American drug policy, the U.S. Drug Enforcement Administration (DEA) will...
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift...